daunorubicin has been researched along with Carcinoma, Non-Small Cell Lung in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 10 (50.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YL; Chen, YW; Liang, CC; Lu, PJ; Tseng, CH; Tzeng, CC; Yang, CN; Yao, YC | 1 |
| Chen, YL; Chiu, CC; Chou, CK; Hsu, CY; Tseng, CH; Tzeng, CC | 1 |
| Fan, L; Fu, M; Li, G; Li, J; Li, X; Liu, J; Pan, W; Wang, X; Wang, Y; Yang, Y; Yu, Y | 1 |
| Cai, YD; Chen, L; Huang, T; Kong, X; Yang, J; Zheng, M | 1 |
| Chalfant, CE; Goehe, RW; Hawkins, AJ; Massiello, A; Mayton, EK; Mukerjee, P; Murudkar, CS; Park, MA; Pinkerman, RL; Shultz, JC; Wijesinghe, DS | 1 |
| Bosch, SV; de Jonge, MJ; Fiorentini, F; Hess, D; Lechuga, MJ; Mantel, MA; Mora, O; Planting, AS; Sessa, C; Valota, O; van der Gaast, A; Verweij, J | 1 |
| Mossink, MH; Scheper, RJ; Schoester, M; Sonneveld, P; van Zon, A; Wiemer, EA | 1 |
| Dekker, H; Lankelma, J; Pinedo, HM; Spoelstra, EC; Westerhoff, HV | 1 |
| Barrand, MA; Rhodes, T; Twentyman, PR | 1 |
| Broxterman, HJ; Dekker, H; Lankelma, J; Mülder, HS; Pinedo, HM | 1 |
| Lankelma, J; Mülder, HS; van Grondelle, R; Westerhoff, HV | 1 |
| Barrand, MA; Center, MS; Rhodes, T; Twentyman, PR | 1 |
| Alvord, WG; Gazdar, AF; Gray-Goodrich, M; Koo, HM; McWilliams, MJ; Mikheev, A; Monks, A; Oie, HK; Paull, KD; Rubinstein, LV; Vande Woude, GF; Zarbl, H | 1 |
| Berger, W; Elbling, L; Hauptmann, E; Micksche, M | 1 |
| Bergman, AM; Kuiper, CM; Peters, GJ; Pinedo, HM; Veerman, G | 1 |
| Berger, W; Elbling, L; Micksche, M | 1 |
| Baptiste, N; Chen, X; Friedlander, P; Prives, C | 1 |
| Broxterman, HJ; de Vries, EG; Feller, N; Kuiper, CM; Lankelma, J; Pinedo, HM; Versantvoort, CH | 1 |
| Baas, F; Borst, P; de Jong, S; de Vries, EG; Eijdems, EW; Jongsma, AP; Nieuwint, AW; van Groenigen, M; Versantvoort, CH | 1 |
| Dombernowsky, P; Hansen, M; Joss, RA; Monfardini, S; Pinedo, HM; Renard, J | 1 |
1 trial(s) available for daunorubicin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Daunorubicin; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 2002 |
19 other study(ies) available for daunorubicin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Discovery of 4-anilinofuro[2,3-b]quinoline derivatives as selective and orally active compounds against non-small-cell lung cancers.
Topics: Administration, Oral; Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mice; Mice, Nude; Mitosis; Models, Molecular; Neoplasm Transplantation; Oximes; Quinolines; Solubility; Stereoisomerism; Structure-Activity Relationship; Tissue Distribution; Topoisomerase Inhibitors; Transplantation, Heterologous | 2011 |
Discovery of 2-[2-(5-nitrofuran-2-yl)vinyl]quinoline derivatives as a novel type of antimetastatic agents.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Discovery; Humans; Lung Neoplasms; Neoplasm Metastasis; Quinolines | 2015 |
Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer.
Topics: A549 Cells; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Movement; Daunorubicin; Diosgenin; Drug Delivery Systems; Female; Humans; Liposomes; Lung Neoplasms; Matrix Metalloproteinase 2; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Oligopeptides; Particle Size; Static Electricity; Wound Healing | 2019 |
The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer.
Topics: Animals; Antineoplastic Agents; Arsenicals; Berberine; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Colchicine; Daunorubicin; Digoxin; Drug Discovery; Humans; Lung; Lung Neoplasms; Ouabain; Prednisone; Small Cell Lung Carcinoma; Tretinoin | 2015 |
SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
Topics: Alternative Splicing; Carcinoma, Non-Small-Cell Lung; Caspase 9; Cell Line, Tumor; Cisplatin; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enhancer Elements, Genetic; Erlotinib Hydrochloride; HeLa Cells; Humans; Introns; Lung Diseases; Nuclear Proteins; Paclitaxel; Quinazolines; RNA Precursors; RNA Splice Sites; RNA-Binding Proteins; RNA, Antisense; RNA, Small Interfering; Serine-Arginine Splicing Factors | 2011 |
Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Nucleus; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fibroblasts; Green Fluorescent Proteins; Humans; Luminescent Proteins; Lung Neoplasms; Male; Mice; Mice, Knockout; Recombinant Fusion Proteins; Transfection; Vault Ribonucleoprotein Particles | 2004 |
The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Culture Media; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Kinetics; Lung Neoplasms; Membrane Glycoproteins; Models, Biological; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil | 1994 |
Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
Topics: 4-Chloro-7-nitrobenzofurazan; Anti-Bacterial Agents; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brefeldin A; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Nucleus; Cyclopentanes; Cytoplasm; Daunorubicin; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Golgi Apparatus; Humans; Lung Neoplasms; Macrolides; Membrane Glycoproteins; Protein Synthesis Inhibitors; Proton-Translocating ATPases; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1994 |
Daunorubicin efflux against a concentration gradient in non-P-glycoprotein multidrug-resistant lung-cancer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Carcinoma, Non-Small-Cell Lung; Daunorubicin; Drug Interactions; Drug Resistance, Multiple; Humans; Hydrogen-Ion Concentration; Intracellular Fluid; Kinetics; Lung Neoplasms; Spectrometry, Fluorescence; Vincristine | 1994 |
A plasma membrane 'vacuum cleaner' for daunorubicin in non-P-glycoprotein multidrug-resistant SW-1573 human non-small cell lung carcinoma cells. A study using fluorescence resonance energy transfer.
Topics: Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Membrane; Computer Simulation; Daunorubicin; Diphenylhexatriene; DNA; Drug Resistance; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Models, Biological; Spectrometry, Fluorescence; Tumor Cells, Cultured; Verapamil; Vincristine | 1993 |
Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein.
Topics: Carcinoma, Non-Small-Cell Lung; Cyclosporine; Cyclosporins; Daunorubicin; Humans; Lung Neoplasms; Membrane Proteins; Molecular Weight; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vincristine | 1993 |
Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Cytarabine; Daunorubicin; Deoxycytidine; DNA Mutational Analysis; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gemcitabine; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Lung Neoplasms; Software; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1996 |
Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells.
Topics: Aged; ATP-Binding Cassette Transporters; Carcinoma, Non-Small-Cell Lung; Daunorubicin; Drug Resistance, Multiple; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multidrug Resistance-Associated Proteins; RNA, Messenger; Tumor Cells, Cultured | 1997 |
Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell lines.
Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Carcinoma, Non-Small-Cell Lung; Daunorubicin; Deoxycytidine; Doxorubicin; Drug Resistance, Multiple; Gemcitabine; Humans; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured | 1998 |
Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cell Line; Cisplatin; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fibroblasts; Gene Expression Regulation; Humans; Lung; Lung Neoplasms; Neoplasm Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles; Vinblastine | 2000 |
The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Clone Cells; Colchicine; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; DNA Damage; DNA, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Lung Neoplasms; Models, Biological; Proline; Promoter Regions, Genetic; Protein Structure, Tertiary; Recombinant Fusion Proteins; Structure-Activity Relationship; Tetracycline; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
Topics: Adenosine Triphosphate; Carcinoma, Non-Small-Cell Lung; Cell Membrane Permeability; Daunorubicin; Drug Resistance; Energy Metabolism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Nigericin; Phenotype; RNA, Messenger; Tumor Cells, Cultured; Vincristine | 1992 |
Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Non-Small-Cell Lung; Cell Fusion; Cell Line; Cell Survival; Daunorubicin; DNA Topoisomerases, Type II; Drug Resistance; Gene Expression; Humans; Kinetics; Lung Neoplasms; Membrane Glycoproteins; Phenotype; RNA, Messenger; Transfection; Vincristine | 1992 |
Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Daunorubicin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Menogaril; Middle Aged; Nogalamycin | 1988 |